Considering our previous results, we speculated that tumor cells of progressive U-CLL cases over-expressing miR-26b-5p take advantage of TGF-β inhibition, avoiding the cell cycle arrest that normally occurs in most CLL cells. Here, TGFB1 is linked to neoplasm.